Seismic Therapeutic, Inc.
Watertown, MA · Founded 2020 · CIK 0002002995 · Biotech · Private
Machine learning-designed biologic medicines for autoimmune and inflammatory diseases
seismictx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $121M
- 1 Form D · Dec 2023
- 34 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 3 granted · 37 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $121,279,929 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2804 | ANSA BIOTECHNOLOGIES, INC. | — | $123M |
| 2805 | Frontier Medicines | — | $122M |
| 2806 | Praxis Precision Medicine | — | — |
| 2807 | Seismic Therapeutic, Inc. | — | $121M |
| 2808 | TRIM-EDICINE INC | — | — |
| 2809 | Orna Therapeutics Holdings, LLC | — | $121M |
| 2810 | Edgewise Therapeutics | — | $120M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Shelley ChuDirector
- Alan CraneDirector
- Julie EastlandDirector
- Edward FreedmanExecutive Officer
- Andrew HedinDirector
- Timothy SpringerDirector
- Joanne VineyDirector · Executive Officer
Patents
- VARIANT IgG FC POLYPEPTIDES AND USES THEREOFapplication
- IgE PROTEASES AND USES THEREOFapplication
- VARIANT IgG FC POLYPEPTIDES AND USES THEREOFapplication
- Protease Variants And Uses Thereofapplication
- Fc Fusion Molecules And Uses Thereofapplication
- Molecules For Modulating The Immune System And Uses Thereofapplication
- Protease Variants And Uses Thereofgranted
- Fc Fusion Molecules And Uses Thereofgranted
- VARIANT IgG FC POLYPEPTIDES AND USES THEREOFgranted
- Dual Targeted Immune Regulating Compositionsapplication
- Dual Targeted Immune Regulating Compositionsapplication
- Systems And Methods For Predicting B-cell Epitopesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.